Lv4
628 积分 2021-03-26 加入
In vivo chimeric antigen receptor (CAR)-T cell therapy
14天前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
1个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
1个月前
已完结
In vivo CAR engineering for immunotherapy
2个月前
已完结
Tumour-derived small extracellular vesicles act as a barrier to therapeutic nanoparticle delivery
2个月前
已完结
Second Primary Cancer After Chimeric Antigen Receptor–T-Cell Therapy
3个月前
已完结
Clinical, tumor and product features associated with outcomes after axicabtagene ciloleucel therapy in follicular lymphoma
3个月前
已完结
Increase in circulating cells coexpressing M1 and M2 macrophage surface markers in patients with systemic sclerosis
4个月前
已完结
An optimized flow cytometry panel for classifying macrophage polarization
4个月前
已完结
Mobilizing antigen-presenting mast cells in anti-PD-1-refractory triple-negative breast cancer: a phase 2 trial
4个月前
已完结
皖公网安备34019202002308
